Article Correctness Is Author's Responsibility: Lysin therapy offers new hope for fighting drug-resistant bacteria

(Rockefeller University) Increasingly, bacteria do not succumb to antibiotics. Rockefeller researchers have developed a new class of antimicrobial drug, lysin, with one compound showing promising results in a clinical trial -- suggesting that an alternative to antibiotics may be on the horizon.